Kurt Jellinger 90: his contribution to neuroimmunology.
Alzheimer’s disease
Experimental autoimmune encephalomyelitis
MOG antibody disease
Multiple sclerosis
Neuroimmunology
Neuropathology
Journal
Journal of neural transmission (Vienna, Austria : 1996)
ISSN: 1435-1463
Titre abrégé: J Neural Transm (Vienna)
Pays: Austria
ID NLM: 9702341
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
22
04
2021
accepted:
27
05
2021
pubmed:
11
6
2021
medline:
30
10
2021
entrez:
10
6
2021
Statut:
ppublish
Résumé
This review honors Kurt Jellinger on his 90th birthday as one of the most outstanding neuropathologists, who has contributed immensely to neuroscience due to his vast experience and collection of excellently documented autopsy cases. Two of his many insightful reports are highlighted here. One report focuses on the pathogenesis of inflammatory demyelinating diseases and investigates the neuropathology in autopsy tissue of a patient, who developed an MS-like disease after repeated treatment with lyophilized bovine brain cells in 1958. More than 60 years later, after reinvestigation of the historic samples in 2015 and subsequent mRNA isolation, next generation sequencing and reconstruction of the antibody, we succeeded in identifying myelin oligodendrocyte glycoprotein (MOG) as the target antigen and provided the missing element between the pathomechanisms in classic EAE animal models and transfer of this disease process into humans. A second significant example of Kurt Jellinger's contribution to neuroscience was a report on the role of MS in the development of Alzheimer's disease (AD), which found that AD pathology is present to the same extent in demyelinated and non-demyelinated cortical areas in MS and the incidence for AD pathology in elderly MS patients is comparable to the normal-aging population. This indicates that chronic inflammation in the MS cortex alone does not significantly predispose to the development of cortical AD pathology. These and other findings were only possible due to the broad collection of extremely well-defined material established by Kurt Jellinger, which ultimately continues to contribute to translational neuroscience, even decades later.
Identifiants
pubmed: 34110492
doi: 10.1007/s00702-021-02358-4
pii: 10.1007/s00702-021-02358-4
pmc: PMC8528743
doi:
Substances chimiques
Antibodies
0
Myelin-Oligodendrocyte Glycoprotein
0
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1545-1550Informations de copyright
© 2021. The Author(s).
Références
Acta Neuropathol. 2021 Jan;141(1):67-83
pubmed: 33242149
Brain. 2017 Dec 1;140(12):3128-3138
pubmed: 29136091
Brain. 2021 Feb 12;144(1):144-161
pubmed: 33578421
Nervenarzt. 1990 Apr;61(4):235-8
pubmed: 1972266
Ann Neurol. 2008 Feb;63(2):174-83
pubmed: 17924575
Z Rechtsmed. 1989;103(1):1-20
pubmed: 2588815
Lancet Neurol. 2016 Feb;15(2):198-209
pubmed: 26724103
J Neuropathol Exp Neurol. 1957 Apr;16(2):139-203; discussion, 203-8
pubmed: 13416937
Acta Neuropathol. 2020 May;139(5):875-892
pubmed: 32048003
J Neuropathol Exp Neurol. 2003 Jan;62(1):25-33
pubmed: 12528815
J Exp Med. 1933 Jun 30;58(1):39-53
pubmed: 19870180
Curr Opin Neurol. 2021 Apr 1;34(2):228-236
pubmed: 33560670
Genes (Basel). 2021 Mar 20;12(3):
pubmed: 33804666
Front Cell Neurosci. 2020 Oct 27;14:599717
pubmed: 33192332
J Neurol. 1980 Jan;222(3):191-204
pubmed: 6153707
Brain. 2012 May;135(Pt 5):1622-38
pubmed: 22539258
Lancet Neurol. 2018 Oct;17(10):918-926
pubmed: 30264730
Brain Pathol. 2018 Nov;28(6):791-805
pubmed: 29222823
Trends Pharmacol Sci. 1994 Dec;15(12):447-50
pubmed: 7886816
Neuropatol Pol. 1966 Jul-Dec;4(3):366-400
pubmed: 5925916
Wien Klin Wochenschr. 1993;105(16):467-71
pubmed: 8212704
Klin Wochenschr. 1958 May 1;36(9):437-41
pubmed: 13550853
Am J Psychiatry. 1994 Aug;151(8):1105-13
pubmed: 7518651
Neuropathol Appl Neurobiol. 2019 Apr;45(3):278-290
pubmed: 29804289
Brain Pathol. 2004 Jan;14(1):43-50
pubmed: 14997936
Nat Rev Neurol. 2013 Aug;9(8):455-61
pubmed: 23797245
Brain. 2017 Jul 1;140(7):1900-1913
pubmed: 28541408
Lancet Neurol. 2016 Mar;15(3):317-31
pubmed: 26724102
Mov Disord. 2016 Dec;31(12):1767-1771
pubmed: 27869324
J Neuropathol Exp Neurol. 2007 Sep;66(9):819-27
pubmed: 17805012
J Neurol. 1975 Dec 2;211(1):51-60
pubmed: 56431
Acta Neuropathol Commun. 2015 Dec 04;3:80
pubmed: 26637427